Search results
Results from the WOW.Com Content Network
Most individuals with a fatty-acid metabolism disorder are able to live a normal active life with simple adjustments to diet and medications. If left undiagnosed many complications can arise. When in need of glucose the body of a person with a fatty-acid metabolism disorder will still send fats to the liver. The fats are broken down to fatty acids.
This lipidation event is the most common type of fatty acylation [3] and is present in many organisms, including animals, plants, fungi, protozoans [4] and viruses. Myristoylation allows for weak protein–protein and protein–lipid interactions [ 5 ] and plays an essential role in membrane targeting, protein–protein interactions and ...
The fatty-acid-binding proteins (FABPs) are a family of transport proteins for fatty acids and other lipophilic substances such as eicosanoids and retinoids. [ 1 ] [ 2 ] These proteins are thought to facilitate the transfer of fatty acids between extra- and intracellular membranes . [ 3 ]
Very long-chain acyl-coenzyme A dehydrogenase deficiency is a fatty-acid metabolism disorder which prevents the body from converting certain fats to energy, particularly during periods without food. [1] [2] [3] Those affected by this disorder have inadequate levels of an enzyme that breaks down a group of fats called very long-chain fatty acids.
Overall, there are three main types of lipid-anchored proteins which include prenylated proteins, fatty acylated proteins and glycosylphosphatidylinositol-linked proteins (GPI). [ 2 ] [ 5 ] A protein can have multiple lipid groups covalently attached to it, but [ clarification needed ] the site where the lipids bind to the protein depends both ...
Medium-chain acyl-CoA dehydrogenase deficiency (MCAD deficiency or MCADD) is a disorder of fatty acid oxidation that impairs the body's ability to break down medium-chain fatty acids into acetyl-CoA. The disorder is characterized by hypoglycemia and sudden death without timely intervention, most often brought on by periods of fasting or vomiting.
Treatment of EET analog is beneficial for hepatic insulin signaling in mouse model of insulin resistance. [47] These interventions also gave beneficial results in animal models of non-alcoholic fatty liver disease and certain types inflammation-related kidney diseases including chronic kidney disease, renal ischemia-reperfusion injury, and ...
Fatty-acyl-CoA synthase, or more commonly known as yeast fatty acid synthase (and not to be confused with long chain fatty acyl-CoA synthetase), is an enzyme complex responsible for fatty acid biosynthesis, and is of Type I Fatty Acid Synthesis (FAS). Yeast fatty acid synthase plays a pivotal role in fatty acid synthesis.